Skip to main content

Table 3 Efficacy and effectiveness data for pneumococcal vaccines

From: Potential cost-effectiveness and benefit-cost ratios of adult pneumococcal vaccination in Germany

 

PCV13

PPV23

 

IPD

Age Group

Efficacy

Serotype Coverage

Efficacy

Serotype Coverage

18 - 39

93.9% [26]*

67.9%

74.0%*[9]

83.3%

40 - 49

75.4%

78.5%

50 - 59

63.4%

78.9%

60 - 69

63.9%

83.6%

70 - 79

71.4%

78.3%

80 - 89

74.8%

84.5%

≥ 90

76.2%

90.5%

 

Inpatient CAP / Outpatient CAP (all cause)

Age Group

Effectiveness

Effectiveness

All

26.0%/6% [27, 28]

0%/0% [6, 9, 19]

  1. * = multiplication.